Cargando…
Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers
The current clinical management model of HER2-positive breast cancers is commonly based on guidelines, which in turn are based on the design and outcome of clinical trials. While this model is useful to most practicing clinicians, the treatment outcome of individual patient is not certain at the sta...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659858/ https://www.ncbi.nlm.nih.gov/pubmed/36387174 http://dx.doi.org/10.3389/fonc.2022.964824 |